National Comprehensive Cancer Network

|
|
|
|
For Patients
NCCN Clinical Practice Guidelines in Oncology™
About the NCCN Clinical Practice Guidelines in Oncology™
Recent Updates to NCCN Clinical Practice Guidelines in Oncology™
NCCN Categories of Evidence and Consensus
NCCN Guidelines Steering Committee
Submission Request to the NCCN Guidelines Panels
NCCN Guidelines Panels-Meeting Schedule
NCCN Drugs & Biologics Compendium™
About the NCCN Drugs & Biologics Compendium™
Compendium Chapters
No Longer Recommended Uses
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

Clinical Recommendations

NCCN 3rd Annual Congress Hematologic Malignancies Program Overview

Clinicians

Register Online

Congress Information

Program Overview

Educational Objectives

Congress Agenda

Satellite Symposia

Intended Audience

Accommodations

Registration Information

Accreditation

Commercial Support

Exhibiting

Refer a Friend

Go back to previous page

 

 

     
 

Program Overview

Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of new advances. In addition, targeted therapies and oral treatments bring new benefits to patients. This program will focus on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.

Last update 03/17/2008.

 
E-mail   Print   Mark   A   A   Size


Bookmark and Share

Quick Links


Upcoming Events


Privacy Policy| Legal Notices| Site Map| Contact Us| Help

Copyright © 2010 National Comprehensive Cancer Network, All Rights Reserved